Metabolismul glucozei în cancer şi rolul dietei cetogene
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
1109 34
Ultima descărcare din IBN:
2023-08-20 19:03
Căutarea după subiecte
similare conform CZU
616.1/.9-006.3.04:613.2.03 (1)
Patologia sistemului circulator, a vaselor sanguine. Tulburări cardiovasculare (975)
Patologia sistemului respirator. Tulburări ale organelor de respiraţie (2679)
Patologia sistemului digestiv. Tulburări ale tubului alimentar (5980)
Patologia sistemului limfatic, a organelor hemopoietice şi endocrine (9439)
Piele. Tegumente în general. Dermatologie clinică. Tulburări cutanate (13087)
Patologia sistemului urogenital. Boli urinare şi sexuale (genitale) (17077)
Patologia organelor de locomoţie. Sistemul osos şi locomotor (21455)
Neurologie. Neuropatologie. Sistem nervos (26715)
Boli transmisibile. Boli infecţionase şi contagioase, stări febrile (32444)
Dietă. Principii de nutriţie aplicate la hrană şi alimente (181)
SM ISO690:2012
LÎSÎI, Dan, TAGADIUC, Olga, SARDARI, Veronica. Metabolismul glucozei în cancer şi rolul dietei cetogene. In: Curierul Medical, 2015, nr. 2(58), pp. 56-64. ISSN 1875-0666.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Curierul Medical
Numărul 2(58) / 2015 / ISSN 1875-0666

Metabolismul glucozei în cancer şi rolul dietei cetogene
CZU: 616.1/.9-006.3.04:613.2.03

Pag. 56-64

Lîsîi Dan, Tagadiuc Olga, Sardari Veronica
 
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“
 
 
Disponibil în IBN: 13 mai 2015


Rezumat

Background: One of the fundamental metabolic characteristics of cancer tissues is high consumption of glucose by cancer cells. The purpose of this article is determination of the features in the energy metabolism of cancer cells, elucidation of energy metabolism due to the major nutritive substrates, such as glucose and glutamine, evaluation of lactate dehydrogenase (LDH) as a potential marker of malignancies, estimation of the ketogenic diet in the treatment of cancer. The cells with higher degree of proliferation have a lower level of reduced Nicotinamide Adenine Dinucleotide (NADH), confirming the hypothesis: anabolic processes are predominant in cancer. The preferred way of glucose utilization in cancer tissues is the conversion of pyruvate to lactate, a phenomenon known as aerobic glycolysis or Warburg effect. Tumors with a high level of aerobic glycolysis are the most aggressive. The fact that LDHA (which catalyzes the reversible reaction of pyruvate to lactate) reflects the aggressiveness of the tumor and demonstrates the importance of aerobic glycolytic metabolism (the Warburg effect) in the survival of tumor cells. Conclusions: Multiple studies have mentioned the possibility of using glutamine instead of glucose by the cancer cells. Use of glutamine is another way of generating energy contributing to tumor cell survival. It was established that on substitution of glucose with ketone bodies (ketogenic diet), cancer cells can not adapt and die. Modulation of energy metabolism represents a new stage in the treatment of cancer. The substitution of glucose with lipids in the feed ration (ketogenic diet) is a non-toxic method of cancer management, both in prevention and treatment .

Cuvinte-cheie
cancer, aerobic glycolysis, lactate dehydrogenase, the Warburg effect,

ketogenic diet.